The Study at a Glance
Peer-reviewed · Indexed in PubMed · Open access on PMC
Journal
The Open Biomedical Engineering Journal
Lead Authors
Yakovleva EG, Korotkov KG
Institutions
Russian National Research Medical University + ITMO University
Status
Pilot study — developing methodology for GDV screening
Before We Begin
This is a pilot study — the authors explicitly describe it as developing a "methodological approach" for using GDV data in screening. It does not claim that Bio-Well can diagnose colon cancer. It investigates whether EPI parameters contain information that could contribute to a screening process. That distinction matters enormously, and we'll hold to it throughout this article.
In This Guide
The Screening Problem That Inspired the Study
Colorectal cancer is one of the most treatable cancers — if caught early. The problem isn't the treatment. It's the screening. Colonoscopy, the gold standard, requires sedation, bowel preparation, and an assistant. Fecal tests exist but have limited sensitivity. The result? Many people who should be screened simply aren't.
This is the gap that caught the attention of researchers at Russia's National Research Medical University in Moscow. Their question was ambitious: Could a painless, 5-minute fingertip scan identify people who should be referred for colonoscopy? Not as a replacement for colonoscopy — but as a non-invasive first step that might catch more people who need it.
Colonoscopy
Accurate but invasive. Requires sedation, bowel prep, medical staff. Many patients avoid or delay it.
Fecal Tests
Non-invasive but limited sensitivity. Misses some tumors. Better than nothing, but not ideal.
EPI Scan (tested here)
Non-invasive, painless, 5 minutes, no prep. Could it serve as a pre-screening step to identify who needs colonoscopy?
Interactive: How They Approached the Problem
The researchers used an engineering-driven approach — treating the problem as a classification challenge. Tap each step to see how they built the pipeline:
What the Data Showed
The study's conclusions were stated directly by the authors:
From the Authors' Conclusions
The study demonstrated the ability to identify patients with colon tumors using EPI technology, as well as to perform differential diagnosis by tumor morphology, size, and quantity. EPI testing is non-invasive, takes less than five minutes, and equipment is relatively inexpensive — opening prospects for use as a first step in a screening process.
Paraphrased from study conclusions. Full text: DOI 10.2174/1874120701610010072
✅
Group Separation
The classification model could separate colon tumor patients from healthy controls using selected EPI parameters.
🔬
Morphology Differentiation
EPI data could distinguish between different tumor types based on their morphological characteristics.
📏
Size Classification
The data carried information about tumor size — suggesting larger tumors produce stronger signals in the emission data.
🔢
Quantity Detection
The model could also differentiate between patients with single versus multiple tumors from the EPI data alone.
The Engineering Approach: Why This Study Is Different
What sets this study apart from the diabetes and HRV studies is the engineering mindset. The previous studies asked "do correlations exist?" This study asks "can we build a system that classifies?"
That's a fundamentally different question. Correlation studies tell you variables are related. Classification studies tell you whether that relationship is strong enough to actually sort people into categories. It's the difference between saying "taller people tend to be heavier" and building a system that can reliably predict someone's weight range from their height.
The fact that the lead institution was the Russian National Research Medical University — a clinical medical school — rather than a physics department, signals that the clinical community is beginning to take EPI technology seriously enough to test it against real diagnostic challenges.
Where This Fits in the Evidence Chain
This study builds on a precursor study by the same team. In 2015, Yakovleva et al. published "Identifying Patients with Colon Neoplasias with Gas Discharge Visualization Technique" in the Journal of Alternative and Complementary Medicine. The 2016 paper extends that work with more sophisticated engineering methods.
| Study | Condition | Approach | Day |
|---|---|---|---|
| Bhat et al., 2016 | Diabetes | Correlation analysis | 15 |
| Cioca et al., 2004 | Autonomic balance | Correlation analysis | 16 |
| Lithuanian U., 2024 | COPD | Case-control comparison | 17 |
| Yakovleva et al., 2016 | Colon tumors | Engineering classification | 18 |
Notice the progression: from correlations (Days 15–16) to group comparisons (Day 17) to classification models (Day 18). Each step represents a higher bar of evidence. The colon tumor study asks not just "are these related?" but "can we use this to make decisions?" — which is ultimately the question that determines whether a technology has clinical utility.
What the Study Can't Tell Us
Pilot study, not clinical trial
The authors describe this as developing a "methodological approach." It demonstrates feasibility — that the approach could work — not that it's ready for clinical deployment. Validation with larger, independent samples is essential before any screening claims can be made.
Sensitivity and specificity unclear
For any screening tool, the critical questions are: How many tumors does it miss? (sensitivity) How many false alarms does it trigger? (specificity) These metrics require large prospective studies that this pilot was not designed to provide.
Korotkov is a co-author
Professor Korotkov — the inventor of the GDV technology — is a co-author on this paper. While this is common in specialized research fields (the inventor often has the deepest expertise), independent replication by teams without any connection to the technology would strengthen the findings.
Does not replace colonoscopy
Even the authors frame EPI as a potential "first step of the screening process" — meaning it would identify people who should be referred for colonoscopy, not replace the definitive procedure. No fingertip scan can substitute for direct visual inspection of the colon.
The honest bottom line: This pilot study demonstrates that EPI data contains information relevant to colon tumor status — enough to build classification models that separate patients from healthy controls. That's a meaningful proof-of-concept published in a peer-reviewed, PubMed-indexed journal. But it's a first step, not a conclusion. The road from "pilot feasibility" to "clinical screening tool" requires large prospective validation studies, independent replication, and formal sensitivity/specificity testing.
Read the full study
The complete paper is freely available on PubMed Central.
Sources Cited in This Article
- Yakovleva EG, Korotkov KG, Fedorov ED, Ivanova EV, Plahov RV, Belonosov SS. "Engineering Approach to Identifying Patients with Colon Tumors on the Basis of Electrophotonic Imaging Technique Data." The Open Biomedical Engineering J. 2016;10:72-80. PMC4994194 → · DOI →
- Yakovleva EG, Buntseva OA, Belonosov SS, Fedorov ED, Korotkov K, Zarubina TV. "Identifying Patients with Colon Neoplasias with Gas Discharge Visualization Technique." J Altern Complement Med. 2015;21(3):155-60. DOI →
- IUMAB Bioelectrography Cancer Research index. iumab.org →
- Korotkov, K. "Review of EPI papers 2008–2018." Int J Complement Alt Med. 2018;11(6). DOI →
- Bio-Well Science page — colon tumor study referenced. bio-well.com/pages/science →
Share:
Find a Bio-Well scan near you: what to expect at your first session
Energy Blockages and Disease: The WHO's Recognition of Traditional Medicine